Clinical Research Directory
Browse clinical research sites, groups, and studies.
Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia
Sponsor: Washington University School of Medicine
Summary
The purpose of this study is to find out which pain medication is more effective in reducing pain after nose surgery (rhinoplasty). The investigators are looking to find the best treatment to reduce discomfort and improve the healing process for patients having nose surgery.
Official title: Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia: A Randomized Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2026-07
Completion Date
2027-07
Last Updated
2026-07-10
Healthy Volunteers
No
Conditions
Interventions
Standard Bupivacaine
Volume: 4 mL of 0.75% bupivacaine hydrochloride
Liposomal Bupivacaine
Volume: 1.5 mL of 0.75% bupivacaine hydrochloride and 2.5 mL of liposomal bupivacaine
Locations (1)
Washington University
St Louis, Missouri, United States